English English Manufactured under strict ISO 9001:2015, ISO 22000, and HACCP validated standards. Each batch is verified via HPLC/UV testing for complete chemical stability in high-humidity regional supply chains.
In-depth structural breakdown of Vitamin K2 MK-7, detailing the biological necessity of strict all-trans conformation, industrial fermentation kinetics, and systemic carboxylating activity.
Vitamin K2 (menaquinone) exhibits pharmacological potency dependent on geometric stereoisomerism. Our Bacillus subtilis var. natto deep-tank liquid fermentation delivers over 99.0% isomeric all-trans MK-7. Cis-isomers are biologically inactive artifacts often found in cheap synthetic variants; they fail to activate human osteocalcin and matrix Gla-protein (MGP) due to steric hindrance inside the gamma-glutamyl carboxylase enzymatic cleft.
Pure menaquinone-7 is vulnerable to alkaline compounds (like calcium carbonate, magnesium oxide) and ambient humidity. In tropical territories such as Castries, unprotected MK-7 degrades by up to 80% within 90 days. BKYULA Biotech utilizes advanced spray-drying microencapsulation using gum acacia, cross-linked octenyl succinate starch, and tocopherol matrices to insulate the lipophilic active against Zone IVb climatic stressors.
Unlike short-chain menaquinones (MK-4) whose systemic clearance occurs in hepatic tissue within 1.5 to 3 hours, our fermentation-derived MK-7 incorporates 7 isoprenoid residues. This grants extraordinary lipophilic affinity, binding with low-density lipoproteins (LDL) and extending plasma half-life to approximately 72 hours. This sustained therapeutic window enables once-daily low-dose therapy (45–180 mcg/day) for target tissue saturation.
| Analytical Metric | BKYULA Fermented MK-7 Powder | Standard Synthetic MK-7 | Conventional Vitamin K2 (MK-4) |
|---|---|---|---|
| Origin / Substrate | Bacillus subtilis var. natto Non-GMO | Chemical Synthesis (Geraniol / Farnesol) | Synthetic Alkylation of Menadione |
| Active Isomer Ratio | >99.2% All-Trans Isomer | Variable (65%–85% Trans, high Cis content) | Single form (Trans stereochemistry) |
| Systemic Elimination Half-Life | Approx. 72 Hours (Continuous tissue uptake) | 40–60 Hours (Interrupted by cis interference) | 1.5–3 Hours (Rapid hepatic clearance) |
| Target Daily Effective Dosage | 45 mcg – 180 mcg / day | 90 mcg – 200 mcg / day | 45,000 mcg / day (Three divided doses) |
| Stability in Tropical Zone IVb (40°C/75% RH) | 96.4% Retention (Microencapsulated) | 54.0% Retention (Standard carrier) | 42.5% Retention (Unprotected crystal) |
| HPLC Traceability & COA Verification | Chiral Column Isomeric HPLC Chromatogram | Routine Standard HPLC (Opaque Cis peaks) | Standard UV-HPLC Assay |
Addressing the specific demographic, clinical, and tourism-driven nutraceutical demands of Saint Lucia, Castries, and OECS medical networks.
Non-communicable diseases (NCDs), particularly cardiovascular complications and arterial calcification, present significant health challenges in the Eastern Caribbean. Vitamin K2 MK-7 serves as an essential cofactor activating Matrix Gla Protein (MGP), the strongest physiological inhibitor of arterial vessel calcification. Supplying local compounding clinics and pharmacies in Castries helps combat arterial stiffness and improves vascular elasticity across the local aging population.
Castries acts as the primary maritime and economic gateway to Saint Lucia's internationally renowned wellness resort sector (Soufrière, Rodney Bay, Cap Estate). Ultra-luxury resorts and medical spas actively develop bespoke anti-aging formulas, bone density maintenance protocols, and clean-label daily longevity sachets. Our microencapsulated, non-GMO, Halal, and Kosher certified MK-7 powder integrates seamlessly into premium resort dietary offerings.
Local Caribbean contract packagers frequently combine Vitamin D3 with calcium carbonate derived from marine sources. Without Vitamin K2 MK-7, elevated calcium intake poses a severe risk of arterial deposition ("the calcium paradox"). BKYULA's microencapsulated MK-7 powder is coated to resist calcium alkalinity, allowing formulators in Castries to produce stable bone density tablets that ensure calcium enters skeletal hydroxyapatite rather than vessel walls.
Strategic perspectives for importers, hospital purchasing departments, and nutraceutical distributors handling pharmaceutical APIs in Saint Lucia.
Castries Harbour operates as an essential transshipment hub for the Organisation of Eastern Caribbean States (OECS). Regional distributors consolidate active pharmaceutical ingredients (APIs) and premixes directly from China via deep-sea routes into Castries before redistributing smaller batches to Dominica, Saint Vincent, Grenada, and Martinique. BKYULA's moisture-barrier export packaging guarantees cargo integrity through prolonged maritime transits.
Importation of active vitamins and therapeutic minerals into Castries requires strict batch-level compliance documentation. BKYULA Biotech supplies an audit-ready dossier with every consignment, including validated HPLC chromatographic traces showing all-trans purity, Certificate of Free Sale (CFS), non-GMO statements, residual solvent tests (USP <467>), and microbiological assays compliant with Caribbean public health standards.
Caribbean formulators are moving away from traditional oily suspensions of Vitamin K2 due to packaging leakage and rapid oxidative rancidity during maritime customs holding. Free-flowing, microencapsulated powder assays (ranging from 1,000 ppm to 10,000 ppm, and up to 98% crystalline pure grade) provide exceptional processing stability for rotary tablet presses and hard-shell encapsulation facilities in Castries.
Verified onsite by SGS Group, BKYULA Biotech operates full-scale manufacturing facilities in Xi'an, Shaanxi, China, delivering dependable bulk actives to over 40 global markets.
Every batch of Vitamin K2 MK-7 powder and botanical extract passes through a six-stage production process: high-potency bio-fermentation, low-temperature vacuum concentration, proprietary microencapsulation matrix coating, spray drying, controlled mesh pulverization, and cleanroom packaging.
Our on-site testing laboratories are equipped with dual-system High-Performance Liquid Chromatography (HPLC) units, UV spectrophotometers, loss-on-drying vacuum ovens, and full bio-containment incubators for comprehensive microbial safety evaluation.
Get CatalogYears of Botanical Extraction & Fermentation Engineering
Annual Global Export Volume (Third-Party SGS Verified)
B2B Trade Export Orders Dispatched Every 6 Months
Average Buyer Rating for Batch Conformity & Purity
Practical commercial, regulatory, stability, and shipping answers tailored to importers and formulators sourcing directly from our China factory.
Our standard Minimum Order Quantity (MOQ) for 1,000 ppm, 2,000 ppm, and 10,000 ppm microencapsulated powder grades is only 1 kilogram, securely packed in multi-barrier aluminum foil bags. For pure crystalline API grades (up to 98% HPLC purity), we accommodate pilot evaluation orders starting from 100 grams to support clinical compounding and small-batch trials in Saint Lucia.
Unprotected Vitamin K2 degrades rapidly under heat and moisture. BKYULA Biotech supplies a specialized microencapsulated grade specifically stabilized for WHO Zone IVb hot and humid climatic conditions (40°C / 75% relative humidity). The active menaquinone core is protected within a double-layer matrix of gum acacia, tocopherols, and starch, maintaining >96% assay retention over a 24-month shelf life.
Every shipment is delivered with a complete documentation packet: a batch-specific Certificate of Analysis (COA) containing exact chiral HPLC all-trans assay data, Material Safety Data Sheet (MSDS), Technical Specification Sheet, Non-GMO Statement, Allergen Declaration, and certified copies of our ISO 9001, ISO 22000, HACCP, Halal, and Kosher certifications. Additional Embassy Legalization is available if required by the Saint Lucia Ministry of Health.
For urgent formulation schedules, research batches, and compounding clinics, express air-courier delivery (via DHL / FedEx / UPS) arrives in Castries (via UVF / SLU airports) within 4 to 7 business days. For bulk manufacturing consignments (25 kg to metric-ton lots), sea freight connects from major Chinese ports (Shanghai, Ningbo, Shenzhen) to Port Castries within 28 to 38 days, handled under CIF, CFR, or DDU/DDP terms.
Yes. BKYULA Biotech offers end-to-end contract formulation and private-label toll manufacturing. We assist Caribbean healthcare clients with custom multi-nutrient blends (such as Vitamin D3 5000 IU + Vitamin K2 MK7 100 mcg + Calcium Citrate), effervescent drink powders, botanical capsules, and sachet stick-packs, all packaged in humidity-sealed containers tailored to tropical retail distribution.
Every commercial production batch undergoes high-resolution chiral column High-Performance Liquid Chromatography (HPLC) testing in our certified Xi'an analytical laboratory. Unlike standard C18 reverse-phase assays that cannot distinguish between stereoisomers, our chiral assay accurately separates inactive cis-isomers from the biologically active all-trans isomer. We certify a minimum all-trans content of 98.0%–99.5% on every official release document.
Connect directly with our technical pharmaceutical sales team. We provide sample testing batches, custom assay formulations, and comprehensive regulatory documentation for direct maritime and air delivery to Castries, Saint Lucia.
